ATRALIN (nda022070)- (0.05%)

Generic Name	TRETINOIN	Innovator	DOW PHARM
Dosage	0.05%
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2014-Sep-23	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2010-Jul-26
GAIN Expiry	None	Drug Complexity	No
Indication	Atralin Gel is a retinoid indicated for topical treatment of acne vulgaris.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
1	0	1

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.05%	**	**	-	1	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	1

Manufacturing Details of ATRALIN